Novel Patient-Friendly Orodispersible Formulation of Ivermectin is Associated With Enhanced Palatability, Controlled Absorption, and Less Variability: High Potential for Pediatric Use.

Saved in:
Bibliographic Details
Title: Novel Patient-Friendly Orodispersible Formulation of Ivermectin is Associated With Enhanced Palatability, Controlled Absorption, and Less Variability: High Potential for Pediatric Use.
Authors: Dao K; Clinical Pharmacology Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Buettcher M; Pediatric Pharmacology and Pharmacometrics Research Center, University Children's Hospital Basel (UKBB), Basel, Switzerland.; Pediatric Infectious Diseases, Children's Hospital of Central Switzerland (KidZ), Lucerne, Switzerland.; Faculty of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland., Golhen K; Pediatric Pharmacology and Pharmacometrics Research Center, University Children's Hospital Basel (UKBB), Basel, Switzerland., Kost J; Department of Pharmaceutical Sciences, Division of Pharmaceutical Technology, University of Basel, Basel, Switzerland., Schittny A; Department of Pharmaceutical Sciences, Division of Pharmaceutical Technology, University of Basel, Basel, Switzerland., Duthaler U; Division of Clinical Pharmacology & Toxicology, Department of Biomedicine, University and University Hospital Basel, Basel, Switzerland.; Division of Clinical Pharmacology & Toxicology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland., Atkinson A; Pediatric Pharmacology and Pharmacometrics Research Center, University Children's Hospital Basel (UKBB), Basel, Switzerland.; Division of Infectious Diseases, Washington University in St. Louis School of Medicine, St. Louis, MO, USA., Haefliger D; Clinical Pharmacology Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Guidi M; Clinical Pharmacology Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.; Center for Research and Innovation in Clinical Pharmaceutical Sciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Bardinet C; Clinical Pharmacology Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Chtioui H; Clinical Pharmacology Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Boulekbache A; Clinical Pharmacology Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Buclin T; Clinical Pharmacology Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Huwyler J; Department of Pharmaceutical Sciences, Division of Pharmaceutical Technology, University of Basel, Basel, Switzerland., Pfister M; Pediatric Pharmacology and Pharmacometrics Research Center, University Children's Hospital Basel (UKBB), Basel, Switzerland., Rothuizen LE; Clinical Pharmacology Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Source: Journal of clinical pharmacology [J Clin Pharmacol] 2024 Oct; Vol. 64 (10), pp. 1295-1303. Date of Electronic Publication: 2024 May 30.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley Country of Publication: England NLM ID: 0366372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1552-4604 (Electronic) Linking ISSN: 00912700 NLM ISO Abbreviation: J Clin Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38813747
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Novel Patient-Friendly Orodispersible Formulation of Ivermectin is Associated With Enhanced Palatability, Controlled Absorption, and Less Variability: High Potential for Pediatric Use.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Dao+K%22">Dao K</searchLink>; Clinical Pharmacology Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Buettcher+M%22">Buettcher M</searchLink>; Pediatric Pharmacology and Pharmacometrics Research Center, University Children's Hospital Basel (UKBB), Basel, Switzerland.; Pediatric Infectious Diseases, Children's Hospital of Central Switzerland (KidZ), Lucerne, Switzerland.; Faculty of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Golhen+K%22">Golhen K</searchLink>; Pediatric Pharmacology and Pharmacometrics Research Center, University Children's Hospital Basel (UKBB), Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Kost+J%22">Kost J</searchLink>; Department of Pharmaceutical Sciences, Division of Pharmaceutical Technology, University of Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Schittny+A%22">Schittny A</searchLink>; Department of Pharmaceutical Sciences, Division of Pharmaceutical Technology, University of Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Duthaler+U%22">Duthaler U</searchLink>; Division of Clinical Pharmacology & Toxicology, Department of Biomedicine, University and University Hospital Basel, Basel, Switzerland.; Division of Clinical Pharmacology & Toxicology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Atkinson+A%22">Atkinson A</searchLink>; Pediatric Pharmacology and Pharmacometrics Research Center, University Children's Hospital Basel (UKBB), Basel, Switzerland.; Division of Infectious Diseases, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.<br /><searchLink fieldCode="AU" term="%22Haefliger+D%22">Haefliger D</searchLink>; Clinical Pharmacology Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Guidi+M%22">Guidi M</searchLink>; Clinical Pharmacology Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.; Center for Research and Innovation in Clinical Pharmaceutical Sciences, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Bardinet+C%22">Bardinet C</searchLink>; Clinical Pharmacology Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Chtioui+H%22">Chtioui H</searchLink>; Clinical Pharmacology Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Boulekbache+A%22">Boulekbache A</searchLink>; Clinical Pharmacology Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Buclin+T%22">Buclin T</searchLink>; Clinical Pharmacology Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.<br /><searchLink fieldCode="AU" term="%22Huwyler+J%22">Huwyler J</searchLink>; Department of Pharmaceutical Sciences, Division of Pharmaceutical Technology, University of Basel, Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Pfister+M%22">Pfister M</searchLink>; Pediatric Pharmacology and Pharmacometrics Research Center, University Children's Hospital Basel (UKBB), Basel, Switzerland.<br /><searchLink fieldCode="AU" term="%22Rothuizen+LE%22">Rothuizen LE</searchLink>; Clinical Pharmacology Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220366372%22">Journal of clinical pharmacology</searchLink> [J Clin Pharmacol] 2024 Oct; Vol. 64 (10), pp. 1295-1303. <i>Date of Electronic Publication: </i>2024 May 30.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0366372 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1552-4604 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200912700%22">00912700 </searchLink><i>NLM ISO Abbreviation: </i>J Clin Pharmacol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38813747
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/jcph.2462
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1295
    Titles:
      – TitleFull: Novel Patient-Friendly Orodispersible Formulation of Ivermectin is Associated With Enhanced Palatability, Controlled Absorption, and Less Variability: High Potential for Pediatric Use.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Dao K
      – PersonEntity:
          Name:
            NameFull: Buettcher M
      – PersonEntity:
          Name:
            NameFull: Golhen K
      – PersonEntity:
          Name:
            NameFull: Kost J
      – PersonEntity:
          Name:
            NameFull: Schittny A
      – PersonEntity:
          Name:
            NameFull: Duthaler U
      – PersonEntity:
          Name:
            NameFull: Atkinson A
      – PersonEntity:
          Name:
            NameFull: Haefliger D
      – PersonEntity:
          Name:
            NameFull: Guidi M
      – PersonEntity:
          Name:
            NameFull: Bardinet C
      – PersonEntity:
          Name:
            NameFull: Chtioui H
      – PersonEntity:
          Name:
            NameFull: Boulekbache A
      – PersonEntity:
          Name:
            NameFull: Buclin T
      – PersonEntity:
          Name:
            NameFull: Huwyler J
      – PersonEntity:
          Name:
            NameFull: Pfister M
      – PersonEntity:
          Name:
            NameFull: Rothuizen LE
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2024 Oct
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1552-4604
          Numbering:
            – Type: volume
              Value: 64
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: Journal of clinical pharmacology
              Type: main
ResultId 1